Loading...
This record has been deleted. Since it is linked to a published record, it is available here for reference purposes only.
Click here to view the deleted recordThis document has been updated. This is not the latest published version. Click here to view the latest version of the record.
Biosafety Virtual Library Resources
(VLR)
last updated: 26 Mar 2012
Key elements in a strategic approach to capacity building in the biosafety of genetically modified organisms
EN
Regulatory Science, International Centre for Genetic Engineering and Biotechnology (ICGEB)
()
BCH-ORG-SCBD-15917-15
- Inter-governmental organization (IGO)
AREA Science Park
Padriciano 99
Trieste,
34149, Italy
Phone: +39-040-37571,
Fax:
Email: regsci@icgeb.org,
EDP Sciences, France
EN
2010
EN
EDP Sciences
EN
© ISBR, EDP Sciences, 2010
EN
Abstract:
In recent times, it has become imperative for countries to define and implement policy in biosafety due to the widespread adoption of genetically modified crops. As such, countries wishing to utilise transgenic technologies in the development of advanced agricultural products must have regulations in place coupled with trained personnel in national competent authorities able to contribute effectively to the decision-making process. Capacity building initiatives play an important role in supporting such individuals, institutions and governmental authorities by providing training and/or physical structures/equipment and technical assistance. There are many types of capacity building activities; however not all have the same relevance in different regions of the world. For capacity building to be effective, a strategic approach incorporating a variety of forms and disciplines is desired. This commentary discusses the importance of factors such as: the targeting of support to relevant beneficiary(ies); the identification of specific needs and the incorporation of socio-economic conditions when elaborating effective strategies designed to help building capacity. Moreover, the importance of interaction and collaboration amongst the various capacity builders is also discussed such that unnecessary duplication of efforts and best use of available human and economic resources results.
EN
In recent times, it has become imperative for countries to define and implement policy in biosafety due to the widespread adoption of genetically modified crops. As such, countries wishing to utilise transgenic technologies in the development of advanced agricultural products must have regulations in place coupled with trained personnel in national competent authorities able to contribute effectively to the decision-making process. Capacity building initiatives play an important role in supporting such individuals, institutions and governmental authorities by providing training and/or physical structures/equipment and technical assistance. There are many types of capacity building activities; however not all have the same relevance in different regions of the world. For capacity building to be effective, a strategic approach incorporating a variety of forms and disciplines is desired. This commentary discusses the importance of factors such as: the targeting of support to relevant beneficiary(ies); the identification of specific needs and the incorporation of socio-economic conditions when elaborating effective strategies designed to help building capacity. Moreover, the importance of interaction and collaboration amongst the various capacity builders is also discussed such that unnecessary duplication of efforts and best use of available human and economic resources results.
- GBF-T17. Strengthen biosafety and distribute benefits of biotechnology
No
No
No
Identifier (ISBN, ISSN, etc.)
DOI: 10.1051/ebr/2010003
Format
7 page PDF file
Keywords and any other relevant information
Keywords: biosafety needs / capacity building / genetically modified organisms (GMOs) / decision-making
Citation: Environ. Biosafety Res. 9 (2010) 59–65